Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FT6ER
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,176
Award facts
- Contract value 100% obligated
- $33,176.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,176.09 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
BIKTARVY, an antiretroviral medication used in HIV treatment, represents one of many specialized pharmaceutical products supplied by AmerisourceBergen through its federal contracts. The DLA Medical Supply Chain leverages the Cencora IDC to procure essential medications across multiple therapeutic domains, including specialty drugs, brand-name and generic pharmaceuticals, and medical devices, to support military treatment facilities and veterans' healthcare programs worldwide. AmerisourceBergen's consistent receipt of competitive awards demonstrates its capability to meet federal procurement requirements for critical healthcare commodities across the defense medical system.
Quick answers
Who was awarded contract SPE2DR26FT6ER?
SPE2DR26FT6ER was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26FT6ER worth?
The government has obligated $33,176 on SPE2DR26FT6ER.
Is contract SPE2DR26FT6ER an order under another contract?
Yes. SPE2DR26FT6ER is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT6ER competed?
The extent of competition for SPE2DR26FT6ER was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award